Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Miyazaki

Showing results (171-180 of 217) with videos related to

Pageof 22
Sort By:
Rheumatology (Oxford, England)|November 7, 2023
Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registryYusuke Miyazaki, Masashi Funada, Shingo Nakayamada, et al.
The Journal of International Medical Research|June 30, 2021
Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessationMaki Komiyama, Yuka Ozaki, Yusuke Miyazaki, et al.
Rheumatology (Oxford, England)|March 14, 2022
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTDYasuyuki Todoroki, Satoshi Kubo, Kazuhisa Nakano, et al.
RMD Open|January 22, 2025
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registryYusuke Miyazaki, Shingo Nakayamada, Hiroaki Tanaka, et al.
Redox Biology|December 5, 2022
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's diseaseFumiaki Nagashima, Yusuke Miyazaki, Eiki Kanemaru, et al.
Annals of the Rheumatic Diseases|October 30, 2023
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotypingHiroaki Tanaka, Yukinori Okada, Shingo Nakayamada, et al.
Rheumatology (Oxford, England)|February 28, 2023
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosusYuya Fujita, Shigeru Iwata, Shinsuke Hidese, et al.
International Journal of Rheumatic Diseases|February 6, 2020
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosusIppei Miyagawa, Kazuhisa Nakano, Shingo Nakayamada, et al.
Journal of Materials Chemistry. B|March 8, 2024
Light-controllable cell-membrane disturbance for intracellular deliveryWenting Huo, Koji Miki, Huiying Mu, et al.
International Journal of Cardiology|October 19, 2016
Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexesYusuke Miyazaki, Yasufumi Katanasaka, Yoichi Sunagawa, et al.
Pageof 22

Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Rheumatology (Oxford, England)|November 7, 2023
Safety and efficacy of anifrolumab therapy in systemic lupus erythematosus in real-world clinical practice: LOOPS registryYusuke Miyazaki, Masashi Funada, Shingo Nakayamada, et al.
The Journal of International Medical Research|June 30, 2021
Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessationMaki Komiyama, Yuka Ozaki, Yusuke Miyazaki, et al.
Rheumatology (Oxford, England)|March 14, 2022
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTDYasuyuki Todoroki, Satoshi Kubo, Kazuhisa Nakano, et al.
RMD Open|January 22, 2025
Switching to biological DMARDs versus cycling among JAK inhibitors in patients with rheumatoid arthritis and with inadequate response to JAK inhibitors: from FIRST registryYusuke Miyazaki, Shingo Nakayamada, Hiroaki Tanaka, et al.
Redox Biology|December 5, 2022
Sulfide:quinone oxidoreductase ameliorates neurodegeneration in a murine model of Parkinson's diseaseFumiaki Nagashima, Yusuke Miyazaki, Eiki Kanemaru, et al.
Annals of the Rheumatic Diseases|October 30, 2023
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotypingHiroaki Tanaka, Yukinori Okada, Shingo Nakayamada, et al.
Rheumatology (Oxford, England)|February 28, 2023
Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosusYuya Fujita, Shigeru Iwata, Shinsuke Hidese, et al.
International Journal of Rheumatic Diseases|February 6, 2020
The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosusIppei Miyagawa, Kazuhisa Nakano, Shingo Nakayamada, et al.
Journal of Materials Chemistry. B|March 8, 2024
Light-controllable cell-membrane disturbance for intracellular deliveryWenting Huo, Koji Miki, Huiying Mu, et al.
International Journal of Cardiology|October 19, 2016
Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexesYusuke Miyazaki, Yasufumi Katanasaka, Yoichi Sunagawa, et al.
Pageof 22